This document discusses the emerging consumer healthcare market as major demographic shifts are increasing demand for products that promote health and wellness. Two industries - consumer goods companies and pharmaceutical companies - are competing to meet this demand. Consumer goods companies excel at marketing but must substantiate health claims, while pharmaceutical companies have strong scientific expertise but face declining drug revenues. It remains to be seen which type of company will dominate the consumer healthcare market by successfully meeting consumer needs through their strengths in either marketing or science.
Connected health, also known as technology-enabled care (TEC), involves the convergence of health technology, digital media, and mobile devices. It enables patients, carers, and healthcare professionals (HCPs) to access data and information more easily and improve the quality and outcomes of both health and social care.
2015 Report: Medicines in Development for Heart Disease & StrokePhRMA
Ā
According to the American Heart Association, someone in the United States dies from cardiovascular disease every 40 seconds, and more than 85 million Americans have at least one form of the disease. Heart disease has been the leading cause of death in the United States since 1921, but these numbers are declining. Read this report by PhRMA - in partnership with the Association of Black Cardiologists - on the nearly 200 medicines in development for heart disease & stroke.
Connected health, also known as technology-enabled care (TEC), involves the convergence of health technology, digital media, and mobile devices. It enables patients, carers, and healthcare professionals (HCPs) to access data and information more easily and improve the quality and outcomes of both health and social care.
2015 Report: Medicines in Development for Heart Disease & StrokePhRMA
Ā
According to the American Heart Association, someone in the United States dies from cardiovascular disease every 40 seconds, and more than 85 million Americans have at least one form of the disease. Heart disease has been the leading cause of death in the United States since 1921, but these numbers are declining. Read this report by PhRMA - in partnership with the Association of Black Cardiologists - on the nearly 200 medicines in development for heart disease & stroke.
2016 Report: Medicines in Development for Alzheimer's DiseasePhRMA
Ā
Today, more than 5 million Americans have Alzheimerās disease. The disease devastates the minds of patients, creates substantial burdens for families and caregivers, and currently costs the health care system more than $200 billion a year. These sobering statistics are projected to get much worse as the 76 million American baby boomers age.
This report shows that America's Biopharmaceutical Research Companies Are Developing More Than 70 Medicines for Alzheimerās Disease
Technology has the power to improve access to healthcare services, especially for people with mobility problems. Mobile technology can empower patients and carers by giving them more control over their health and making them less dependent on HCPs for health information.
The pharmaceutical industry will be characterised by heightened uncertainty in 2017, mainly due to inevitable changes to the politicised US health system.
Pricing is expected to remain the key issue, and providers of goods and services, especially those with questionable cost-benefit profiles, can expect further scrutiny. Emerging pharmaceutical markets are also in a cycle of under-performance compared with developed markets.
Despite all the challenges facing the healthcare sector, we nevertheless maintain a positive outlook. Investors will continue to be attracted to the robust fundamentals that support innovation and the consequential generation of high margins.
Medical Device Development - Trends, Challenges and RisksDina Sifri
Ā
Med-Dev Design is an innovative company specializing in medical device development.
The Med-Dev team of exceptional software engineers bring more than a decade of broad range experience in developing medical devices.
Company services cover all aspects of medical device development, including: product and project management, software design, software development, software architecture, software verification and validation as well as documentation for the regulatory bodies.
This report looks at consumer healthcare trends in Vietnam, Asia. It explores drivers behind the growth in the pharmaceutical industry, changing attitudes to healthcare, prevalence of diseases and treatments. The report considers the relative influence of consumers, pharmacies and healthcare practitioners for marketing budgets.
Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Puncheslouiesmith
Ā
Being one of the best manufacturers, suppliers and exporters of Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Punches and Tablet Compression Machine Spares in India.
The Marriage of Lean and MES in Medical Device Manufacturing - Jim Robinson, ...marcus evans Network
Ā
For more information contact: Slideshare@marcusevans.com.
The Marriage of Lean and MES in Medical Device Manufacturing - Presentation delivered by Speaker James Robinson, Vice President, Operations, Advanced Bionics, at the marcus evans Medical Device Manufacturing Summit held on June 25-26, in Las Vegas
2016 trends in global medical device strategy and issues for the supply chainTony Freeman
Ā
In its 2016 annual review of the global medical device supply chain Manning Advisors identifies two core trends driving both OEM and supplier strategy. The first trend, consolidation, has paused to allow integration of large acquisitions made in the last three years. The second trend, changing products to compete in a fee-for-value rather than fee-for-service reimbursement environment, drives new technologies and capabilities. These trends continue to redistribute favored firms in medical devices.
Biomanufacturing and Medical Device Manufacturing at Ivy Tech Community Collegebio-link
Ā
Dr. Sengyong Lee compares biomanufacturing and medical device manufacturing and talks about the programs for educating students in these areas at Ivy Tech Community College.
Staying Relevant in a High Volume, Commoditized, Medical Device Product Line ...marcus evans Network
Ā
Beth Krenzer, Cardinal Health - Speaker at the marcus evans Medical Device Manufacturing Summit Spring 2012, held in Las Vegas, NV, delivered his presentation entitled Staying Relevant in a High Volume, Commoditized, Medical Device Product Line in Manufacturing (Insourced and Outsourced)
2016 Report: Medicines in Development for Alzheimer's DiseasePhRMA
Ā
Today, more than 5 million Americans have Alzheimerās disease. The disease devastates the minds of patients, creates substantial burdens for families and caregivers, and currently costs the health care system more than $200 billion a year. These sobering statistics are projected to get much worse as the 76 million American baby boomers age.
This report shows that America's Biopharmaceutical Research Companies Are Developing More Than 70 Medicines for Alzheimerās Disease
Technology has the power to improve access to healthcare services, especially for people with mobility problems. Mobile technology can empower patients and carers by giving them more control over their health and making them less dependent on HCPs for health information.
The pharmaceutical industry will be characterised by heightened uncertainty in 2017, mainly due to inevitable changes to the politicised US health system.
Pricing is expected to remain the key issue, and providers of goods and services, especially those with questionable cost-benefit profiles, can expect further scrutiny. Emerging pharmaceutical markets are also in a cycle of under-performance compared with developed markets.
Despite all the challenges facing the healthcare sector, we nevertheless maintain a positive outlook. Investors will continue to be attracted to the robust fundamentals that support innovation and the consequential generation of high margins.
Medical Device Development - Trends, Challenges and RisksDina Sifri
Ā
Med-Dev Design is an innovative company specializing in medical device development.
The Med-Dev team of exceptional software engineers bring more than a decade of broad range experience in developing medical devices.
Company services cover all aspects of medical device development, including: product and project management, software design, software development, software architecture, software verification and validation as well as documentation for the regulatory bodies.
This report looks at consumer healthcare trends in Vietnam, Asia. It explores drivers behind the growth in the pharmaceutical industry, changing attitudes to healthcare, prevalence of diseases and treatments. The report considers the relative influence of consumers, pharmacies and healthcare practitioners for marketing budgets.
Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Puncheslouiesmith
Ā
Being one of the best manufacturers, suppliers and exporters of Tablet Punching Machine, Rotary Tablet Press Machine, Dies and Punches and Tablet Compression Machine Spares in India.
The Marriage of Lean and MES in Medical Device Manufacturing - Jim Robinson, ...marcus evans Network
Ā
For more information contact: Slideshare@marcusevans.com.
The Marriage of Lean and MES in Medical Device Manufacturing - Presentation delivered by Speaker James Robinson, Vice President, Operations, Advanced Bionics, at the marcus evans Medical Device Manufacturing Summit held on June 25-26, in Las Vegas
2016 trends in global medical device strategy and issues for the supply chainTony Freeman
Ā
In its 2016 annual review of the global medical device supply chain Manning Advisors identifies two core trends driving both OEM and supplier strategy. The first trend, consolidation, has paused to allow integration of large acquisitions made in the last three years. The second trend, changing products to compete in a fee-for-value rather than fee-for-service reimbursement environment, drives new technologies and capabilities. These trends continue to redistribute favored firms in medical devices.
Biomanufacturing and Medical Device Manufacturing at Ivy Tech Community Collegebio-link
Ā
Dr. Sengyong Lee compares biomanufacturing and medical device manufacturing and talks about the programs for educating students in these areas at Ivy Tech Community College.
Staying Relevant in a High Volume, Commoditized, Medical Device Product Line ...marcus evans Network
Ā
Beth Krenzer, Cardinal Health - Speaker at the marcus evans Medical Device Manufacturing Summit Spring 2012, held in Las Vegas, NV, delivered his presentation entitled Staying Relevant in a High Volume, Commoditized, Medical Device Product Line in Manufacturing (Insourced and Outsourced)
The State of Consumer Healthcare: A Study of Patient ExperienceProphet
Ā
There is a vital change happening in healthcare: People are demanding to be treated as savvy consumers, who deserve choices, convenience and fair prices. The same revolution of consumerism thatās shaking up the way the world buys financial services, airline tickets and groceries is finally underway in healthcare. And as healthcare options multiply, this trend will only accelerate. Providers who are ready to respond by creating a strong patient experience are going to win, and those who arenāt will be left behind.
This presentation explains findings from the patient experience study which was conducted to understand the consumer healthcare experience by assessing the gap between patient and providersā expectations and perceptions, and arm institutions with the ability to assess their own organization, define a successful strategy, and deliver on it.
View the webinar here: http://bit.ly/1RLgTFX
The most common method of drug delivery is oral dosage
form of which tablet and capsule are predominant.
Tablet is more accepted as compared to capsule due to
many reason such as cost, tamper resistance, ease of
handling, ease of identification and manufacturing efficiency.
Tablet compression process understanding is resulted in
development of formulation.
Recent advances in the design of tablet compression
equipment has conducted resulted in higher efficiency,
minimized tablet variation, greater flexibility.
This document gives detailed information regarding the processes followed in a Pharma Manufacturing Company.
It also includes graphical representation, for easy understanding.
The Worldās Health Care Crisis: From the Laboratory Bench to the Patientās Be...Elsevier
Ā
Ibis SĆ”nchez-Serrano, founder and CEO of The Core Model Corp., a corporate strategy and policy think tank, talks about the role of pharma in the Worldās Health Care Crisis at the New York Public Library on Aug. 29, 2013. He says the major problem is lack of access to better, safer and more affordable medicines. This issue is present not only in the United States and the developing world but also in countries with socialized health care systems. This illustrated talk will provide a comparative analysis of healthcare systems throughout the world and address major issues within biotechnology and pharmaceutical industries.
Personalized nutrition from DNA - Use your diet to protect you from chronic d...Omar Fogliadini
Ā
Eating well made simple
MANAGE YOUR WEIGHT - WITHOUT WORRYING ABOUT CALORIES.
Lose weight
Eat healthier
Boost immunity
Balance hormones
Get allergy control
Relieve indigestion
EATING WELL MADE SIMPLE
Translate your test results into a personalized nutrition plan
Learn what supplements your body really needs
Quit the numbers game. Stop counting calories
MANAGE STRESS AND SLEEP
Use your diet as first defense against chronic conditions
Use food to manage stress and sleep
Identify foods that stress your body
THE SMART WAY TO TAKE CHARGE OF YOUR HEALTH
Get so many insights from your DNA that no doctor could ever tell you
Hear what your body has to say and live better - by your own rules
A healthy lifestyle is especially hard to do alone. Now you've a Personal Health Coach that customizes your advice before you slip from being healthy into the early stage of an illness.
Future of health - An initial perspective - Devi ShettyFuture Agenda
Ā
An initial perspective on the future of health by Dr Devi Shetty, Chairman and Founder of Narayana Health in India. This is the starting point for the global future agenda discussions taking place through 2015 as part of the the futureagenda2.0 programme. www.futureagenda.org
Running head Healthy people 2020Healthy people 2020 .docxcowinhelen
Ā
Running head: Healthy people 2020
Healthy people 2020 2
Healthy people 2020
Diabetes mellitus
Introduction
This is a disease that results from the bodyās inability to produce enough insulin or inability of the body to produce an appropriate response to insulin. This is the hormone regulation the way the body absorbs glucose. The improper functioning of the insulin in the body may result in elevated levels of blood glucose resulting in various abnormal metabolic activities. This finally results in complications in the body functioning. I am interested in this illness because of its prevalence currently. Across the globe, the number of individual suffering from diabetes mellitus has increased in the past ten years and that has brought this concern. Currently, in the United States, the effect is estimated at 29.1 million. The disease has been classified by the healthy people 2020 initiative group as occupying the 7nth position among the leading causes of death currently.
Morbidity and comorbidity in the United States
There are various disparities in the diabetes risk. The people from the minority population are most likely to suffer from type 2 diabetes. The minority groups, in this case, comprises 25% of the adult patient suffering from diabetes in the United States. The majority group comprises the children and adolescent with diabetes type 2. According to the healthy people initiate 2020, the African American, American Indians, and some Asian Americans are at higher risk of suffering from type 2 diabetes. The prevalence of this illness among the American Indians is 2-5 times that of the whites. Averagely, African Americans are 1.7 times as likely compared to Mexican Americans (Healthy people 2020, 2016). There are some barriers to the progress of diabetes care. The first one being the challenges arising from the design of the healthcare system and the other one being the continuous increase of diabetes cases. This results to decrease in the attention and resources available for every patient. Apart from the two, there are other comorbidities associated with diabetes. These include fracture risks, cancer risk, and prognosis, cognitive impairment, and incontinence.
Impact on health of the nation
Though manageable, diabetes is still one of the diseases posing a major health threat to the United States population and its healthcare system. This illness affects approximately 26 million people in this country with approximately 18.8 million people diagnosed and about seven million not yet diagnosed. Diabetes comes with an array of health issues. Among them being lower limb amputation, it has been determined to possibly cause blindness and kidney failure. Again, it contributes a lot to cardiovascular diseases. Research has indicated that approximately 68% of people suffering from diabetes end up dying of cardiovascular diseases. Economically, research shows that in 2012, this illness caused the United States to close to ...
Nutraceuticals: The Front Line of the Battle for Consumer HealthSemalytix
Ā
Nutrition products can be an inexpensive and safe solution to tackle important unmet health needs.
Consumer healthcare has become the battleground where pharmaceutical and consumer goods firms compete for growth. With more people around the world dying from obesity than starvation, poor nutrition is now recognized as a major risk factor for chronic diseases. Most health systems are ill-equipped to deal with this trend.1 Increasingly, patients are being encouraged to take part in their own treatments, and a consumer market has been developing midway between the supermarket-based world of consumer goods companies and the scientific, pharmacy-based world of pharmaceutical firms.2
The front lines of this battle are nutritional products that have been proven to help prevent or cure disease. These "nutraceuticals" present a tantalizing opportunity for breakthroughs to prevent and manage common health problems, offering consumer-focused solutions to issues that are currently addressed only by pharmaceutical interventionsāor not at all.3 However, despite being a hot spot for growth, they still suffer from the same challenges as the rest of the sector, with market growth barely keeping up with the rise in gross domestic product.4
In this paper, the third in our Winning the Battle for Consumer Healthcare series, we delve further into the nutraceuticals market to understand the opportunities and barriers to growth. We also look at the successes and challenges faced by both consumer goods and pharmaceutical companies as they struggle to gain the upper hand in this exciting new market.
- See more at: http://www.atkearney.com/paper/-/asset_publisher/dVxv4Hz2h8bS/content/nutraceuticals-the-front-line-of-the-battle-for-consumer-health/10192#sthash.Fx04jdM8.dpuf
Marketing may be regarded as comprising four key elements known as the 4 Ps product, price, place and promotion. Food marketing describes any form of advertising used to promote the purchase and or consumption of a food or beverage. It can influence food behaviors by moderating socio cultural elements of the food environment. This paper provides a primer on food marketing. Matthew N. O. Sadiku | Tolulope J. Ashaolu | Sarhan M. Musa ""Food Marketing: A Primer"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-4 , June 2019, URL: https://www.ijtsrd.com/papers/ijtsrd23640.pdf
Paper URL: https://www.ijtsrd.com/other-scientific-research-area/other/23640/food-marketing-a-primer/matthew-n-o-sadiku
Nutraceutical vs pharmaceutical_industryCLARAsteven7
Ā
Nutraceutical vs pharmaceutical industry:Is it a case of complementing or competing against each other?
for more information log on to www.interlinkconsultancy.com
Shaping Sustainable Food Systems for Healthy Diets and Improved Nutrition: Im...ExternalEvents
Ā
Shaping Sustainable Food Systems for Healthy Diets and Improved Nutrition: Implementing the ICN2 Framework for Action Recommendations
Patrick Webb
Friedman School of Nutrition Science and Policy
Tufts University
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Ā
Discover the innovative and creative projects that highlight my journey throughĀ Full Sail University. Below, youāll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Ā
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
What is the TDS Return Filing Due Date for FY 2024-25.pdfseoforlegalpillers
Ā
It is crucial for the taxpayers to understand about the TDS Return Filing Due Date, so that they can fulfill your TDS obligations efficiently. Taxpayers can avoid penalties by sticking to the deadlines and by accurate filing of TDS. Timely filing of TDS will make sure about the availability of tax credits. You can also seek the professional guidance of experts like Legal Pillers for timely filing of the TDS Return.
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
Ā
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
Attending a job Interview for B1 and B2 Englsih learnersErika906060
Ā
It is a sample of an interview for a business english class for pre-intermediate and intermediate english students with emphasis on the speking ability.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Ā
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
Putting the SPARK into Virtual Training.pptxCynthia Clay
Ā
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Ā
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
š¢ Email Access
š¢ Bank Added
š¢ Card Verified
š¢ Full SSN Provided
š¢ Phone Number Access
š¢ Driving License Copy
š¢ Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1āŖ(218) 203-5951ā¬
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
Kseniya Leshchenko: Shared development support service model as the way to ma...Lviv Startup Club
Ā
Kseniya Leshchenko: Shared development support service model as the way to make small projects with small budgets profitable for the company (UA)
Kyiv PMDay 2024 Summer
Website ā www.pmday.org
Youtube ā https://www.youtube.com/startuplviv
FB ā https://www.facebook.com/pmdayconference
Cracking the Workplace Discipline Code Main.pptxWorkforce Group
Ā
Cultivating and maintaining discipline within teams is a critical differentiator for successful organisations.
Forward-thinking leaders and business managers understand the impact that discipline has on organisational success. A disciplined workforce operates with clarity, focus, and a shared understanding of expectations, ultimately driving better results, optimising productivity, and facilitating seamless collaboration.
Although discipline is not a one-size-fits-all approach, it can help create a work environment that encourages personal growth and accountability rather than solely relying on punitive measures.
In this deck, you will learn the significance of workplace discipline for organisational success. Youāll also learn
ā¢ Four (4) workplace discipline methods you should consider
ā¢ The best and most practical approach to implementing workplace discipline.
ā¢ Three (3) key tips to maintain a disciplined workplace.
1. 1Winning the Battle for Consumer Healthcare: Science Versus the Marketers
WinningtheBattleforConsumerHealthcare
Science Versus
the Marketers
This paper is the first in a series on the fight between
consumer goods and pharmaceuticals for an
emerging new market. One industry is strong in
marketing; the other shines in science. Which will win?
3. 3Winning the Battle for Consumer Healthcare: Science Versus the Marketers
Sources: NHS, Age UK: Research into Ageing, Dementia Report 2010, WHO Diabetes and Obesity Atlas, IDF, Cancer Research,
National Osteoporosis Society; A.T. Kearney analysis
Figure 1
Changing demographics create risk factors that accelerate the growth of chronic diseases
Demographic shifts Risk factors Chronic diseases
Wealth
Lifestyle
Urbanization
Obesity
Smoking
Longevity
Osteoporosis
Diabetes
Cancer
Vascular disease
Dementia
are at greater risk of suffering from one or several chronic diseases, including osteoporosis,
diabetes, cancer, vasculitis, and dementia (see figure 1).
Indeed, the incidence of chronic disease is rising at an alarming pace. And the health risk
factors (obesity, smoking, and longevity) are expected to accelerate throughout the next
decade. Today, 45 percent of the United Kingdomās total population can lay claim to one of the
three main risk factors; by 2020, this figure is expected to be 60 percent. Developing countries
are experiencing the same trends. In India, for example, 25 percent of todayās population have
one of the risk factors; in 2020, it is estimated this figure will rise to 40 percent (see figure 2).
Sources: NHS, UK Research on Ageing, Economist Intelligence Unit, Dementia 2010 Report, WHO Diabetes Atlas and Obesity Atlas,
IDF, Cancer Research, National Osteoporosis Society; A.T. Kearney estimates
Figure 2
Health risk factors are expected to accelerate over the next decade
Developed market example: UK Developing market example: India
Population(millions)
Population(millions)
Adult smokingLongevity Population with no risk factorAdult obesity
62
84
891
130
88
223
836
215
2009 2020e
~25% total
population with
risk factors
~40% total
population with
risk factors
276
526
2009 2020e
10
10
34
8 28
13
21
28
4
~45% total
population with
risk factors
~60% total
population with
risk factors
38
4. 4Winning the Battle for Consumer Healthcare: Science Versus the Marketers
Most health systems are ill equipped to deal with an explosion of chronic diseases associated
with these risk factors. Long-term management requires changing the behaviors that caused
the diseases and many years of treatment with a variety of drugs. However, todayās health
systems have generally been designed around short-term interventions, with only about 50
percent of patients taking their medicines as prescribed. Thus, the cost burden is huge. A diabetic
patient in the United States is estimated to consume more than three times the health resources
of a non-diabetic.1
Although different countries are approaching the problem in different ways, three major trends
are encouraging consumers to participate in their treatments:
Increased focus on prevention. Governments and payers are investing in public health
campaigns to convince citizens to change behaviors and begin early treatment, focusing
primarily on obesity and smoking. They are also providing incentives for doctors to identify
those at risk and engage them in their own treatments.
Increased consumer spending. In the developed world, payers are experimenting with
different co-payment mechanisms to both reduce the cost of healthcare and encourage
appropriate behaviors. In the developing world, as emerging health systems fail to keep up
with the expectations of their citizens, consumer spending is filling the gap. Between 2000
and 2015, for example, consumer spending on healthcare services is forecast to increase
130 percent in India, nearly 80 percent in China, and more than 70 percent in Thailand.
Newspendingtrendsasaresultofanagingworldpopulation. By 2030, 36 percent of Germans
and 30 percent of Chinese will be older than 60 years of age, and more than one million
centenarians will be living in the United States. These older populations will have a wide
range of self-medication options and aspirations, including maintaining fitness levels, preserving
youthful appearance, preventing fractures, halting muscle decay, and staving off dementia.
Consumer goods companies can use
their marketing might and access to
mass-market channels to crowd out
first-mover rivals.
The consumer market is developing around these trends, as science provides solutions to meet
increased consumer demand. With greater understanding of how diet and behavior influence
the development of disease, scientists are finding ways to reverse negative effects. The diets of
those at risk of heart disease, for example, have long leaned toward avoiding foods that would
increase cholesterol; now theyāre evolving to include cholesterol-lowering foods. Similar
advances are being made to address risk factors for diseases such as diabetes and osteoporosis.
Now, mass-market productsāincluding food and drinks, personal-care products, and OTC
pharmaceutical-type productsāshow great promise for helping consumers avoid disease.
Of course, this consumer focus has some less benign effects. A tendency also exists to
āmedicalizeā conditions that in past years might have been deemed to be quite normal
1
āState of Diabetes Complications in America,ā American Association of Clinical Endocrinologists
5. 5Winning the Battle for Consumer Healthcare: Science Versus the Marketers
consequences of aging. The whole area is also extremely susceptible to fads. For example,
the evidence that many of the so-called superfoods have any real effect is often extremely
weak, and research suggests that many health food supplements may actually be harmful.
Effective or not, demand is growing for products that people believe will make them healthier.
Which companies will be best placed to meet this demand?
New Battlegrounds
To meet the increasing demand for these products, a whole new consumer healthcare segment
is emerging, midway between the mass market, supermarket-based world of consumer goods
companies and the scientific, pharmacy-based world of pharmaceutical companies (see figure 3).
This new segment is largely occupied by fragmented niche players, but those players are likely to
be swallowed up or swept aside by the incipient entry of giants. Indeed, as populations with risk
factors grow (again, by 2020 itās likely to be about 60 percent of the population of a country such
as the United Kingdom and about 40 percent of India), healthcare products will move to the heart
of the mass market.
The battle has already begun. Many pharmaceutical companies, facing structural declines in
the value of their branded drug portfolios, are focusing more on nonprescription products.
Consumer goods companies are planning to increase margins and accelerate growth by
enriching products with health-oriented features. It has been known since 1984, for example,
6. 6Winning the Battle for Consumer Healthcare: Science Versus the Marketers
that a strong link exists between blood cholesterol and heart diseaseāa link that led to Lipitor,
Pfizerās cholesterol-lowering treatment, becoming the worldās best-selling drug. By 2009, this
class of drugāwhich includes Crestor, Questran, and Lescolāwas worth more than $25 billion.
The industry has also made pushes into OTC remedies such as the nonprescription Zocor
Heart-Pro.2
To build on its strengthsāmaking and proving claims, capitalizing on medical
endorsements, and accessing pharmacy channelsāthe pharmaceutical industry focuses on the
technical aspects of these products. Theyāre packaged in white, functional boxes, for example,
to make them look like the prescription products they replace.
Meanwhile, many niche manufacturers have developed OTC anti-cholesterol products,
including Raisio Groupās Benecol, Cedar Healthās Lestrin, and Futurebioticsā Cholesterol
Balance.3
Consumer goods companies are also offering products designed to lower cholesterol:
Kelloggās Optivita cereal, for example, boasts of its oat bran. Danacol Danone, a dairy drink,
contains plant sterols, which are also the key to Unileverās Flora pro.activ product line of drinks,
yogurts, and spreads. The selling point for all of these products is that they help lower cholesterol,
but their makersāseeking to build on strengths in mass-market distribution, brand development,
and understanding of consumer needsāfocus on the productsā appeal to consumers. For
example, the products come in colorful packages designed to build emotional associations.
As is often expected in any new market, both sets of players have made missteps. Itās hard to
know exactly how to price such products, convince consumers that they will deliver on their
health promises, find the most effective distribution channels and marketing media, assemble
complementary ingredients (for example, does it hurt the health claims of food products when
they contain genetically modified organisms or artificial sweeteners?), or build loyalty. The
smartest companies are learning from these experiences. Going forward, some companies
will refine their approach and become global leaders. The only question is: Which companies
will they be?
Which Companies Will Win?
According to a quote attributed to Mark Twain, āHistory does not repeat itself, but it does rhyme.ā
If so, the pharmaceutical companies are in trouble. Traditionally, consumer goods companies
have mastered the art of using their marketing might and access to mass-market channels to
crowd out more specialized first-mover rivals (see sidebar: Traditionally, Marketers Beat Scientists
on page 7). In some segments of the consumer health market, we already see these forces at work.
Take probiotic yogurt drinks, for exampleātheyāre mass-market products focused on health
benefits. The market for probiotic yogurt drinks did not exist in Europe in the early 1990s, when
the Japanese company Yakult made its regional launch. Yakult was a classic small innovator,
with technical expertise gleaned from having marketed its small bottles of āfriendly bacteriaā
in Japan since 1935. Its drink proved relatively popular, penetrating 1 percent of UK households
by 1999. That was enough to prompt Danone to launch its Actimel brand. Actimel had a huge
advertising campaign and could take advantage of Danoneās powerful distribution network
and innovation pipeline. Danone, therefore, kept introducing new flavors of Actimel. By 2002,
Actimel was slightly ahead of Yakult, and during the next three years, its penetration tripled to
2
Merck has likewise sought to make Mevacor available over the counter, but its attempts have been rejected by the
U.S. Food and Drug Administration.
3
Other niche player products include Advocate LifeCare Cholesterol Health Capsules, Natrol Cholest Intercept, Klosterfrau Kwai Plus
Omega-3, Nature Made Nutritional Productsā Cholest Off and Cholesterol Fighter, Natureās Bounty CholestHealth, and Windmill Health
Products Prevention Cholesterol Control Plant Sterol Formula.
9. 9Winning the Battle for Consumer Healthcare: Science Versus the Marketers
products and are pointlessly subjecting themselves to potential adverse side effects and others
who think the products are sufficient to manage their condition, when in fact they need to be
under a doctorās care.6
In a broader picture, any consumer health product is part of a health
solution, which may include other products, services, or technologies (see sidebar: Technologies
and Solutions). One key to the long-term success of any product, therefore, may be in
positioning it appropriately in the overall package of careāand endorsement by healthcare
professionals will be critical in this process. This āmedical detailingā is a core competency of
pharmaceutical companies, but quite foreign to the mass-market distribution models of many
consumer goods companies.
Looking for the Sweet Spot
No company will create this market in toto or dominate it in the short run. Not every company
can address every opportunity. Companies will necessarily focus on a limited number of
Technologies and Solutions
Gadget-loverswereabuzzin
2010overaniPhoneandAndroid
appcalledInstantHeartRate,
aheartbeatmonitorthatuses
thedeviceāsbuilt-incamera.
Thenearlyfreetool,whichsenses
theminisculechangesinskin
colorresultingfrompulsing
blood,washailedascreativeand
surprisinglyaccurate.Italso
signaledanimminenttrendin
consumerhealthcare.
As pharmaceutical and consumer
goods companies battle over
global healthcare revenues, their
rivals include a surprising new
twist on the idea of a niche player:
app developers. Harnessing their
creative approaches to existing,
prevalent technologies, app
developers drop their prices to
almost zeroāerasing bigger
playersā potential revenue gains.
But app developers face the same
challenges as other players. For
example, smartphone-based
heart-rate monitors are targeted
at athletes as a way to monitor
heartbeat while exercising. As
several such devicesā warning
labels note, however, āThis
monitor is not a medical device
and is not intended to monitor
health concerns.ā If users have
a heart condition, they need
a proven medical device. Despite
its innovative design, therefore,
the Instant Heart Rate app is
missing its full consumer
healthcare potential.
Atleast,thatāshowitstandsnow.
However,pharmaceutical
companieshavedeveloped
dozensofiPhoneappstosupport
thequitecomplexclinicalassess-
mentsoftenneededtoprescribe
drugsproperly.Itmightnotbe
longbeforelow-costappsbecome
goodenoughformanyuses,
especiallyindevelopingcountries
wheremoresophisticated
technologiesarenotreadily
availableandmobilephonesare
notubiquitous.Despitethe
requirementforregulatory
approval,themobilephone
asahubforarangeofmedical
devicesmaynotbefaraway.
The most intriguing potential
use of technological tools in
consumer healthcare is as
components of wider solutions.
Consider Weight Watchers: It
started as a serviceāmeetings
providing weight-loss support.
It evolved into food plans,
exercise plans, and then specific
productsā foods sold under the
Weight Watchers label. Now its
website, with its eTools program,
is an essential component. Why
wouldnāt other preventive health
players also evolve into
platforms?
One such attempt has been
GlaxoSmithKlineās Alli, an OTC
weight-loss product that comes
in starter kits containing a food
journal, a healthy eating guide,
and a fat and calorie reference
guideāor with the Web-based
myalliplan, with weekly advice,
articles, recipes, tips, an online
community, and customized
tools. As an early entrant, Alliās
Web platform is goodābut we
predict that in the coming
decade, the mix of product and
technology solutions will become
far more widespread and
sophisticated.
6
āWhy Merck Lost Its 3rd Bid to Sell Mevacor Over the Counter,ā Natural News, 4 February 2008
10. 10Winning the Battle for Consumer Healthcare: Science Versus the Marketers
markets because of the investments required in applying science, proving efficacy, and
marketing. The trick will be to identify those areas that are set to grow the most and to
establish where an individual company is most likely to be successful.
We believe the key to success will be for each company to identify and target its sweet spots
in the new consumer healthcare market. A sweet spot exists where the following conditions
come together:
A health need thatās not addressed by the state. What do demographic and epidemiological
trends, scientific research, and other new developments suggest about how people can
improve their health? Is this an area that has been recognized as important, or could people be
educated to understand its importance? Government health systems and structures are set
up to provide funding and access to some treatmentsābut not others. Is this one of the
others, in which targeting consumers may be profitable?
A potential consumer market thatās accessible to your company. Do consumers have the
wealth to afford this product and attitudes to adopt it? Will they see it as something important
that will make a difference for themselves or their loved ones? Do they have the products,
brands, distribution, and competitive advantage to meet those customer needs?
Identifying the sweet spots will be only the first step. To execute successfully, the consumer
healthcare players will have to assemble the right mix of capabilities. The challenge, in
summary, is to develop effectively targeted, packaged, and promoted products that are
available to a large number of consumers and deliver what they promise. Aspects of this
challenge draw on sources of competitive advantage for both pharmaceutical and consumer
goods firms (see figure 4).
Source: A.T. Kearney analysis
Figure 4
Consumer goods and pharmaceutical firms have different sources of competitive advantage
Pharmaceutical companies
Low
1 2 3 4
High
5
Pharmaceutical
company advantages
Fast-moving consumer
goods advantages
FMCG companies
Organizational capabilities
Research
Regulations
and compliance
Product
innovation
Manufacturing
Marketing
Sales
Distribution
and logistics
ā¢ Robust molecule pipeline
ā¢ Ability to meet regulatory
requirements at lower costs
ā¢ Ability to meet and prove claims
ā
ā
ā¢ Medical endorsements
and detailing
ā¢ Access to pharmaceutical
channels
ā
ā
ā
ā¢ Innovation leadership
(line extensions)
ā¢ Efficient product development
ā¢ Mass-market production
ā¢ Brand strength
ā¢ Ability to respond
to consumer needs
ā¢ Access to mass market
ā¢ Efficient supply chain
11. 11Winning the Battle for Consumer Healthcare: Science Versus the Marketers
Pharmaceutical companies have the clear edge on research, regulations, and compliance.
With their molecule pipeline, ability to fulfill regulatory requirements at low costs, and
experience at making and proving claims, pharmaceutical companies have the technical
expertise and reputation to make consumers healthier. They have marketing and sales
functions that play to these strengths, with effective medical endorsements and good access
to pharmacy sales channels. They also have the brands to demonstrate clinical capability,
even if they are often wary of diluting those brands by association with less well-proven
technologies. These strengths alone, however, will not be enough to win: These companies
must become capable of far more rapid product innovation and must build flexible supply
chains capable of reacting to the promotion-driven sales patterns of consumer goods. They
must better understand consumers and their aspirations and improve their ability to adjust
product mix and marketing to meet those desires while keeping costs low.
Consumer goods companies face a nearly opposite situation. They are traditionally strong in
both speedy product development and incremental innovation and line extension to meet
evolving consumer needs. Their marketing is good at establishing brands, which will be
especially important in developing countries, where regulations are less of a barrier, and
responding to consumer aspirations. Their manufacturing operations and supply chains are
agile and efficient at producing and delivering mass-market products. They also use their
presence in mass retail to make the products available to everyone. They have profound
weaknesses, however, on the scientific sideāwhich is, after all, much of what this market is
about. Their brands also may not be extendable into more clinically oriented productsāfizzy
drinks are not readily associated with obesity reduction. If consumers and regulators do not
believe that these products will improve health, then nothing else matters. If these companies
cannot produce the research, meet the regulations, and prove their claims, they too will fail.
The winning companies, therefore, will be those able to marry the yin and the yang into a mixed
model, with some features from each industry (see figure 5). They need to possess certain
attributes of pharmaceutical companies:
Source: A.T. Kearney analysis
Figure 5
Winning companies in this new market will marry the yin and the yang
Excellence in marketing
strategies and execution
Strong brand portfolios that
dominate categories
Flexible and lean
supply chain
Products with proven
efficacy and credibility
Innovation leader with the
courage to lead the market
Global development
versus local deployment
Intimacy with and
understanding of customers
Vision of future
market trends
Access to mass retail
Consumer company characteristics
Pharma company characteristics
Consumer and pharma characteristics
12. 12Winning the Battle for Consumer Healthcare: Science Versus the Marketers
ā¢ Products with proven efficacy and credibility with both consumers and health professionals
ā¢ Health innovation leadership, including the courage to lead the market with new technologies
And they need to display the following characteristics of consumer goods companies:
ā¢ Intimacy with and understanding of customers
ā¢ Strong brand portfolios that dominate categories
ā¢ Excellence in marketing strategies and execution
ā¢ Flexible and lean supply chains
ā¢ Access to mass retail
Most companies will find it difficult to launch new consumer healthcare brands and businesses
from within their existing marketing- or science-dominated cultures. New entrants are typically
setting these ventures up as separate business units. Launches will require new thinking and
approaches and dedicated cross-functional teams to shape the strategy, develop the capabilities,
and mobilize the resources for success. In fact, the unique set of potential roadblocks makes it
hard to predict which companies from the pharmaceutical or consumer goods industries will
dominate the consumer healthcare market. One thing seems certain, however: Among the
unsuccessful will be those companies that donāt dare to try.
Authors
Jonathan Anscombe, partner, London
jonathan.anscombe@atkearney.com
Emmanuel Hembert, principal, Zurich
emmanuel.hembert@atkearney.com
Michael Thomas, partner, London
michaelwilliam.thomas@atkearney.com